PPC

Pilgrim's Pride Corporation (PPC) - Q3 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended September 28, 2025, and the nine-month period ended on the same date. Pilgrim's Pride Corporation is a global food company primarily engaged in the production of chicken, with pork and lamb operations in the U.K. The company operates in three reportable segments: U.S., Europe, and Mexico. As of the reporting date, JBS S.A. beneficially owned 82.3% of the company's outstanding common stock.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 3.8% quarter-over-quarter (QoQ) and 3.5% year-over-year (YoY) for the nine-month period. The U.S. segment drove growth with a 2.3% QoQ increase, while Europe grew 6.4% QoQ. Mexico sales declined 1.7% YoY for the nine months, primarily due to a 10% unfavorable foreign currency translation impact from the Mexican peso depreciation.
• Profitability: Operating income decreased 3.1% QoQ to $492.6 million but increased 17.5% YoY for the nine-month period to $1.41 billion. The YoY improvement was driven by a significant reduction in restructuring charges ($60.2 million decrease) and improved gross margins in the U.S. and Europe segments.
• Restructuring: Restructuring activities were significantly lower in Q3 2025 ($1.8 million) compared to Q3 2024 ($30.8 million), reflecting the winding down of major initiatives in the Europe segment.
• Liquidity Impact: Cash and cash equivalents decreased from $2.04 billion at year-end 2024 to $612.6 million at Q3 2025. This reduction was primarily due to the payment of special cash dividends totaling approximately $2.0 billion ($1.5 billion in April and $500 million in September).
• Capital Expenditures: Capital expenditures increased significantly to $437.3 million for the nine months ended September 28, 2025, compared to $285.8 million in the prior year period, driven by growth projects including a new prepared foods facility in Georgia.

Guidance, Outlook, and Risks

Management Commentary: Management highlighted strong demand in retail and foodservice channels, particularly in the U.S., though supply outpaced demand late in the quarter, pressuring prices. In Europe, sales prices increased to pass through higher input costs (feed, labor, utilities). The company expects cash flows from operations and credit facilities to provide sufficient liquidity for the next 12 months.

Risks and Contingencies:

• Legal Proceedings: The company is involved in the "Broiler Antitrust Litigation," with Phase 2 discovery commenced. To date, $645.1 million has been incurred for settlements with "Broiler Opt Outs." A settlement in the Hogan v. Pilgrim's Pride case was approved, with $41.5 million paid in May 2025.
• Tax Matters: A dispute with the Mexican Tax Administration Service regarding the 2015 acquisition of Tyson de México remains under appeal, with an amount under appeal of approximately $269.5 million. The company has accrued an immaterial amount for this probable loss.
• Market Risks: The company faces exposure to commodity price fluctuations (corn, soybean meal, wheat), foreign currency exchange rates (particularly the Mexican peso and British pound), and inflationary pressures on labor and energy costs.
• Operational Risks: Risks include avian influenza outbreaks, product contamination, and supply chain disruptions.

Key Facts for Investor Verification

• Dividend Impact: Verify the sustainability of future capital returns given the $2.0 billion reduction in cash reserves from special dividends paid in 2025.
• Antitrust Exposure: Monitor the status of the Broiler Antitrust Litigation and potential future settlement costs beyond the $645.1 million already incurred.
• Debt Repurchase Program: Track the execution of the expanded $700 million bond repurchase program and its impact on interest expense and leverage ratios.
• Foreign Currency Sensitivity: Assess the impact of the Mexican peso's depreciation on the Mexico segment's reported earnings and the company's hedging effectiveness.
• Capital Project ROI: Evaluate the progress and expected returns on the $437 million in capital expenditures, specifically the new Georgia facility scheduled for completion in 2027.